Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

The Lancet

21 ta ish

Jurnal · ISSN 0140-6736

AkademScholarda batafsil koʻrsatkichlar

  1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Theo Vos, Stephen S Lim, Cristiana Abbafati +97

    MaqolaOchiq kirishGlobal Maternal and Child HealthThe Lancet202017 iqtibos
    ABI

  2. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Christopher J L Murray, Aleksandr Y. Aravkin, Peng Zheng +97

    MaqolaOchiq kirishHealth, Environment, Cognitive AgingThe Lancet20209 iqtibos
    ABI

  3. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement

    Gretchen A Stevens, Leontine Alkema, Robert E. Black +16

    Sharh maqolaOchiq kirishHealth Systems, Economic Evaluations, Quality of LifeThe Lancet20165 iqtibos
    ABI

  4. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4

    James E. Bennett, Gretchen A Stevens, Colin Mathers +15

    MaqolaOchiq kirishGlobal Public Health Policies and EpidemiologyThe Lancet20184 iqtibos
    ABI

  5. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

    Marissa B Reitsma, Parkes Kendrick, Emad Ababneh +97

    MaqolaOchiq kirishSmoking Behavior and CessationThe Lancet20214 iqtibos
    ABI

  6. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    Claudia Allemani, Tomohiro Matsuda, V Di Carlo +97

    MaqolaOchiq kirishGlobal Cancer Incidence and ScreeningThe Lancet20183 iqtibos
    ABI

  7. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories

    Kyle J Foreman, Neal Marquez, Andrew J. Dolgert +35

    MaqolaOchiq kirishInsurance, Mortality, Demography, Risk ManagementThe Lancet20183 iqtibos
    ABI

  8. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah +97

    MaqolaOchiq kirishCOVID-19 and healthcare impactsThe Lancet20202 iqtibos
    ABI

  9. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

    Haidong Wang, Kaja Abbas, Mitra Abbasifard +97

    MaqolaOchiq kirishGlobal Maternal and Child HealthThe Lancet20202 iqtibos
    ABI

  10. NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4

    James E. Bennett, Vasilis Kontis, Colin Mathers +13

    Sharh maqolaOchiq kirishGlobal Public Health Policies and EpidemiologyThe Lancet20202 iqtibos
    ABI

  11. Tackling cancer: time for a global response

    Franco Cavalli

    MaqolaAdvances in Oncology and RadiotherapyThe Lancet20161 iqtibos
    ABI

  12. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

    Marissa B Reitsma, Nancy Fullman, Marie Ng +97

    MaqolaOchiq kirishSmoking Behavior and CessationThe Lancet20171 iqtibos
    ABI

  13. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015

    Ryan M Barber, Nancy Fullman, Reed J D Sorensen +97

    MaqolaOchiq kirishGlobal Maternal and Child HealthThe Lancet20171 iqtibos
    ABI

  14. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study

    Gilles R. Dagenais, Darryl P. Leong, Sumathy Rangarajan +29

    MaqolaOchiq kirishGlobal Health and EpidemiologyThe Lancet20191 iqtibos
    ABI

  15. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Rafael Lozano, Nancy Fullman, John Everett Mumford +97

    MaqolaOchiq kirishHealthcare Systems and ReformsThe Lancet20201 iqtibos
    ABI

  16. ON THE POSSIBILITY OF ACHIEVING BY PARTIAL PNEUMOTHORAX THE ADVANTAGES OF COMPLETE PNEUMOTHORAX IN THE TREATMENT OF PULMONARY TUBERCULOSIS

    W PARRYMORGAN

    MaqolaOchiq kirishMycobacterium research and diagnosisThe Lancet19130 iqtibos
    ABI

  17. To treat or not to treat? Implementation of DOTS in Central Asia

    Helen Cox, Sally Hargreaves

    MaqolaTuberculosis Research and EpidemiologyThe Lancet20030 iqtibos
    ABI

  18. Dora Akunyili: scourge of Nigerian drug counterfeiters

    Anne Harding

    MaqolaReligion and Sociopolitical Dynamics in NigeriaThe Lancet20060 iqtibos
    ABI

  19. From emergency multilateralism to resilient health diplomacy

    Brian Li Han Wong, Esperanza Martinez, Garry Aslanyan +3

    BoshqaOchiq kirishGlobal Health and SurgeryThe Lancet20250 iqtibos
    ABI

  20. Improving survival and reducing suffering for children with NCDs

    James R. Downing, Tedros Adhanom Ghebreyesus, Asilbek Khudayarov +2

    BoshqaChildhood Cancer Survivors' Quality of LifeThe Lancet20250 iqtibos
    ABI

  21. The relevance of WHO behavioural health insights

    María Romay‐Barja, Ivana Brkic Bilos, E Bratu +10

    BoshqaOchiq kirishGlobal Public Health Policies and EpidemiologyThe Lancet20250 iqtibos
    ABI